Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
bro john 那天我讲980时是以短线切入的看法事实也是如此那天980确实买得到，接着也反弹了！（我没有买，因为我觉得长期他还会跌）
但是市场的反弹不代表反转也不代表行情变好，因为不断往下的趋势已经形成是不会轻易改变的！所以所谓的支撑在上攻行情可以参考，但是下跌行情支撑只能用来跌破！
如果短线建议最基础的不要看这种被压在ma 200 ma 120 ma 60的股！浪费时间罢了
会玩的只看强势股也只玩上升股！
话说回来买这只股的多数是打算用来制作自己的组合的某一角罢了！
至于拿他来赚差价抱歉容我一笑而过，毕竟有些人连低点都猜不透！如果那天980你一买昨天friday 套利刚刚好！至于现在估计下个星期还会跌的没有做好亏损准备就暂时观望吧！
includes brand value, goodwill, and intellectual property like trademarks, patents, and copyrights etc. They are accounted for only if purchased from outside and not made within the company
* The Company has been developing the Med-Tech system, which would provide a seamless automated integration service, and would look for partnership opportunities with medical providers, insurance companies and third-party administrators for this business.
* It would be a high margin business segment, as most of the cost is incurred for the initial set up.
* There is currently no competitor for the Med-Tech business in Malaysia. Such solution is prevalent in other regions such as the western countries, but not for Asia. There will be opportunities for such market, subject to the regulation and licensing requirements of the respective countries.
Scicom (MSC) Berhad (SCIC MK)*
*BUY (maintain) Price Target: RM1.43*
*Up/Downside: 17.2% Previous Target (Rating): RM1.33 (BUY)*
*Earnings are sequentially weaker, but within expectations*
➢ Scicom’s 9MFY23 core net profit grew by 8% yoy to RM24.7m on the back
of higher contribution from the e-services segment. The results were within
market and our expectations
➢ 3QFY23 core net profit fell by 22% qoq to RM7.2m due to lower revenue
from both the BPO and e-services segments). Nonetheless, management
has maintained an interim dividend of 2 sen for 3QFY23, bringing its
9MFY23 DPS to 6 sen (9MFY22: 5.0 sen)
➢ Maintain BUY with higher TP of RM1.43 (from RM1.33) on rolling forward
our valuation base to 2024. We continue to like Scicom for its high ROE
business model that focuses on digital solutions and e-services, attractive
valuation of 12x CY24E PER and CY24E dividend yield of 6.7%
